563 results on '"Ammari, Samy"'
Search Results
2. Trifluridine/tipiracil + oxaliplatin ± nivolumab vs FOLFOX ± nivolumab in HER2 negative advanced oesogastric adenocarcinoma: The PRODIGE73-UCGI40-LOGICAN trial
3. Intratumoral Immunotherapy: Is It Ready for Prime Time?
4. Imaging-guided prognostic score-based approach to assess the benefits of combotherapy versus monotherapy with immune checkpoint inhibitors in metastatic MSI-H colorectal cancer patients
5. Immunosuppressant mycophenolate mofetil for patients with steroid-refractory immune-related hepatitis induced by checkpoint inhibitors in oncology
6. Prognostic factors of the synovial sarcoma of the extremities: imaging does matter
7. Profile and outcome of cancer patients enrolled in contemporary phase I trials
8. Clinical transfer of AGuIX®-based radiation treatments for locally advanced cervical cancer: MR quantification and in vitro insights in the NANOCOL clinical trial framework
9. Synthetic MR image generation of macrotrabecular-massive hepatocellular carcinoma using generative adversarial networks
10. Immune-related generalised oedema – A new category of adverse events with immune checkpoint inhibitors
11. Protective effect of obesity on survival in cancers treated with immunotherapy vanishes when controlling for type of cancer, weight loss and reduced skeletal muscle
12. Generative adversarial networks (GAN)-based data augmentation of rare liver cancers: The SFR 2021 Artificial Intelligence Data Challenge
13. High serum LDH and liver metastases are the dominant predictors of primary cancer resistance to anti-PD(L)1 immunotherapy
14. Prevalence and outcome of steroid-resistant/refractory pneumonitis induced by immune checkpoint inhibitors
15. Contribution of an Artificial Intelligence Tool in the Detection of Incidental Pulmonary Embolism on Oncology Assessment Scans.
16. Patterns of disease events and causes of death in patients with HPV-positive versus HPV-negative oropharyngeal carcinoma
17. Investigating of the role of CT scan for cancer patients during the first wave of COVID-19 pandemic
18. Imaging of Brain Metastases: Diagnosis and Monitoring
19. RCP Pacifique : bilan après un an et 323 cancers rares et/ou complexes discutés
20. Low Doses of Radiation Increase the Immunosuppressive Profile of Lung Macrophages During Viral Infection and Pneumonia
21. Systematic Screening of COVID-19 Disease Based on Chest CT and RT-PCR for Cancer Patients Undergoing Radiation Therapy in a Coronavirus French Hotspot
22. Theragnostic Gadolinium-Based Nanoparticles Safely Augment X‑ray Radiation Effects in Patients with Cervical Cancer.
23. Dosimetry-Driven Quality Measure of Brain Pseudo Computed Tomography Generated From Deep Learning for MRI-Only Radiation Therapy Treatment Planning
24. Integrating Artificial Intelligence and PET Imaging for Drug Discovery: A Paradigm Shift in Immunotherapy
25. Patterns of progression in patients treated for immuno-oncology antibodies combination
26. Determinants of the outcomes of patients with cancer infected with SARS-CoV-2: results from the Gustave Roussy cohort
27. Prognostic 18F-FDG PET biomarkers in metastatic mucosal and cutaneous melanoma treated with immune checkpoint inhibitors targeting PD-1 and CTLA-4
28. Baseline metabolic tumor burden on FDG PET/CT scans predicts outcome in advanced NSCLC patients treated with immune checkpoint inhibitors
29. Mechanisms and therapeutic implications of hypermutation in gliomas
30. Radiomics machine-learning signature for diagnosis of hepatocellular carcinoma in cirrhotic patients with indeterminate liver nodules
31. Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients
32. Risk-based stratification in head and neck mucosal melanoma
33. Outcome of Patients with Non–Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors
34. Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study
35. Computed tomography evaluation after induction chemotherapy for T3 laryngeal cancer: Does response correlate with vocal cord mobility?
36. Recent Advances in the Field of Artificial Intelligence for Precision Medicine in Patients with a Diagnosis of Metastatic Cutaneous Melanoma
37. Integrating [18F]-Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography with Radiation Therapy and Immunomodulation in Precision Therapy for Solid Tumors
38. Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1
39. Kinetics and nadir of responses to immune checkpoint blockade by anti-PD1 in patients with classical Hodgkin lymphoma
40. Neutrophilia as a biomarker for overall survival in newly diagnosed high-grade glioma patients undergoing chemoradiation
41. Circulating oncometabolite D-2-hydroxyglutarate enantiomer is a surrogate marker of isocitrate dehydrogenase–mutated intrahepatic cholangiocarcinomas
42. Prognostic and theranostic 18F-FDG PET biomarkers for anti-PD1 immunotherapy in metastatic melanoma: association with outcome and transcriptomics
43. Evaluation of the efficacy of immunotherapy for non-resectable mucosal melanoma
44. 2488: MRI-based method of AGuiX quantification and correlation with clinical outcomes of the NANOCOL trial
45. Artificial Intelligence and Radiomics: Clinical Applications for Patients with Advanced Melanoma Treated with Immunotherapy
46. Synergic prognostic value of 3D CT scan subcutaneous fat and muscle masses for immunotherapy-treated cancer
47. Baseline lymphopenia should not be used as exclusion criteria in early clinical trials investigating immune checkpoint blockers (PD-1/PD-L1 inhibitors)
48. Standardization of brain MR images across machines and protocols: bridging the gap for MRI-based radiomics
49. Imaging of Brain Metastases: Diagnosis and Monitoring
50. Diagnostic and prognostic value of 18F-FDG PET, CT, and MRI in perineural spread of head and neck malignancies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.